Skip to main content
. 2009 May 28;39(5):185–189. doi: 10.4070/kcj.2009.39.5.185

Fig. 1.

Fig. 1

Comparison of recurrence rates between the persistent and paroxysmal atrial fibrillation groups with and without the use of ACEIs or ARBs. A: recurrence rate in persistent AF. B: recurrence rate in paroxysmal AF. ACEIs: angiotensin converting enzyme inhibitors, ARBs: angiotensin II type 1 receptor blockers.